Understanding How ANVISA Impacts Clinical Trial Design: A Complete Tutorial Navigating Regulatory Landscapes in Latin America Overview This article examines the pivotal role of ANVISA, Brazil's regula...
Understanding How ANVISA Impacts Clinical Trial Design: A Complete Tutorial Navigating Regulatory Landscapes in Latin America Overview This article examines the pivotal role of ANVISA, Brazil's regulatory authority for clinical trials, in shaping the design and execution of clinical research studies. It underscores that ANVISA enforces rigorous guidelines and requirements, including the necessity for comprehensive clinical trial applications and strict adherence to ethical practices. These measures not only safeguard participant safety and ensure compliance but also cultivate an environment that promotes innovative medical research. Introduction In the dynamic landscape of clinical research, Brazil's regulatory framework is pivotal in shaping trial conduct, ensuring that innovation aligns with stringent safety and ethical standards. At the forefront of this regulatory oversight is ANVISA, the Brazilian Health Regulatory Agency, tasked with the critical mission of safeguarding public h…